Consonance Capital Management LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$14.8 - $21.15 $35.1 Million - $50.2 Million
-2,374,392 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$15.21 - $25.53 $7.13 Million - $12 Million
-468,992 Reduced 16.49%
2,374,392 $36.4 Million
Q2 2020

Aug 14, 2020
BUY
$15.08 - $26.0 $9.09 Million - $15.7 Million
602,605 Added 26.89%
2,843,384 $72.4 Million
Q1 2020

May 15, 2020
BUY
$11.0 - $19.76 $24.6 Million - $44.3 Million
2,240,779 New
2,240,779 $34.7 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $693M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email